Broach Lifecare Hospital Limited has declared the voting results of its 3rd Annual General Meeting (AGM) held on September 30, 2026. All three ordinary resolutions proposed at the meeting were passed by the shareholders.

The meeting was conducted through Video Conferencing and Other Audio-Visual Means. The disclosures were made to BSE Limited in compliance with Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Voting details and attendance

The record date for the AGM was September 23, 2026, with 171 shareholders on the register. Voting was conducted via remote e-voting between September 27 and September 29, 2026. During the meeting, five promoter group members and three public shareholders attended through video conferencing.

Rahul S. Mithaiwala & Co., acting as the scrutinizer, submitted the consolidated report on October 1, 2026. The company subsequently filed the results with BSE on October 2, 2026.

Resolutions passed

The shareholders approved the adoption of audited standalone financial statements for the financial year ended March 31, 2026. The resolution received 100% votes in favour from those polled.

The re-appointment of Jaykumar Narendra Vyas as Managing Director, who retired by rotation, was also approved. While promoters voted unanimously in favour, public non-institutional shareholders cast 30,000 votes against the re-appointment, resulting in 99.28% support overall.

The appointment of Rahul S. Mithaiwala & Co. as Secretarial Auditor for a five-year term was ratified with 100% votes in favour.

Summary of voting results

Firm profile

Rahul S. Mithaiwala & Co. is based in Surat and holds Certificate of Practice number 11556 with Peer Review No. 1910/2022. The firm provides services in Corporate Laws, Corporate Governance, FEMA, Startup Advisory, Income Tax, GST Advisory, and Statutory Compliances. The appointment term extends from FY27 to FY31.

Broach Lifecare Hospital Limited recorded a significant expansion in its top line during the financial year 2025-26, with revenue from operations rising 88.55% to ₹599.47 lakh. Despite this robust growth, the company’s net profit contracted sharply to ₹8.68 lakh from ₹53.59 lakh in the previous year, primarily driven by elevated operating expenses.

The findings were disclosed during the proceedings of the company’s third Annual General Meeting (AGM), held on September 30, 2026, via video conferencing. The Board of Directors recommended no dividend for FY26, citing the need to conserve resources and strengthen the company’s financial position amidst ongoing growth and capacity requirements.

Financial performance and operational metrics

The hospital chain, operating under the brand Maple Hospitals, demonstrated substantial year-on-year growth in its core business activities. However, the bottom-line performance indicates pressure on margins as the company scaled its operations.

The divergence between the near-doubling of revenue and the steep decline in net profit highlights a period of intense investment or cost escalation relative to income generation. The statutory auditor, M/s. K. K. Haryani & Co., Chartered Accountants, did not raise any qualifications or adverse remarks regarding the financial statements for the year.

Governance and compliance updates

During the AGM, shareholders approved several key resolutions through remote e-voting facilitated by National Securities Depository Limited (NSDL). The agenda included the adoption of audited financial statements and the re-appointment of Managing Director Jaykumar Narendra Vyas.

Key resolutions passed:

• Adoption of audited financial statements for FY26.
• Re-appointment of Jaykumar Narendra Vyas as Managing Director.
• Appointment of M/s. Rahul S. Mithaiwala & Co. as Secretarial Auditor for five years (FY27-FY31).

The Secretarial Auditor noted two compliance lapses: a delay in filing the Reconciliation of Share Capital Audit Report for the quarter ended December 2025, and non-filing of Form MGT-14 for the appointment of certain auditors. The company stated it has strengthened internal monitoring mechanisms to prevent recurrence.

What the numbers show

A critical observation from the FY26 results is the inverse relationship between volume growth and profitability. While revenue nearly doubled, net profit fell by over 80%, suggesting that incremental costs associated with scaling operations significantly outpaced revenue gains. This pattern often indicates heavy upfront capital expenditure or operational inefficiencies during a rapid expansion phase, which may impact short-term shareholder returns given the decision to withhold dividends.